Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Statins reported to reduce blood pressure in nonhypertensive subjects

Nov. 22, 2004

Pexelizumab reduces mortality in patients undergoing CABG and aortic valve surgery

Nov. 18, 2004

Antiatherosclerotic effects of oral apolipoprotein A-I mimetic

Nov. 18, 2004

Aldosterone synthase inhibition with FAD-286: a novel therapy for the treatment of CHF

Nov. 18, 2004

Full enrollment achieved in phase III study of Celacade for PAD

Nov. 18, 2004

Antiatherosclerotic activity of S-1627 revealed in two species

Nov. 17, 2004

Hemodynamic, renal effects of tolvaptan studied in congestive heart failure model

Nov. 17, 2004

Antirestenotic activity of MS-275 measured in vitro, in vivo

Nov. 17, 2004

Novel von Willebrand factor antagonist prevents occlusive thrombus formation in vivo

Nov. 17, 2004

Lower incidence of death and MI found with pexelizumab after CABG surgery

Nov. 16, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.